Hirudin as anticoagulant for cardiopulmonary bypass: importance of preoperative renal function
- 1 January 2000
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 69 (1) , 37-41
- https://doi.org/10.1016/s0003-4975(99)01289-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Recombinant Hirudin (Lepirudin) Provides Safe and Effective Anticoagulation in Patients With Heparin-Induced ThrombocytopeniaCirculation, 1999
- Emergent Cardiopulmonary Bypass in Five Patients with Heparin-induced Thrombocytopenia Type II Employing Recombinant HirudinAnesthesiology, 1998
- Heparin-associated Thrombocytopenia and ThrombosisAnesthesiology, 1997
- Monitoring of r-Hirudin Anticoagulation during Cardiopulmonary Bypass – Assessment of the Whole Blood Ecarin Clotting TimeThrombosis and Haemostasis, 1997
- Rekombinantes Hirudin als Antikoagulans für den kardiopulmonalen Bypass in der Herzchirurgie: Klinische ErfahrungenZeitschrift für Herz-,Thorax- und Gefäßchirurgie, 1997
- Cross-reactivity study of low molecular weight heparins and heparinoid in heparin-induced thrombocytopeniaThrombosis Research, 1996
- Use of recombinant hirudin as antithrombotic treatment in patients with heparin‐induced thrombocytopeniaAmerican Journal of Hematology, 1995
- Heparinless cardiopulmonary bypass with ancrodThe Annals of Thoracic Surgery, 1994
- Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial RevascularizationAnesthesiology, 1990
- Heparin-associated ThrombocytopeniaAnesthesiology, 1988